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Abstract: The aim of the present study is to provide a strategy for predicting the production of antigenic regions of Clostridium novyi
alpha toxin. The selection is based on B-cell epitopes and MHCII binding protein by immunoinformatics tools. The study resulted in
identifying antigenic regions in the beginning and middle (3–17 and 965–997 amino acid residues) as suitable binders to MHCII and
the carboxyl terminal of the protein (1800–1958 amino acid residues) in B-cell epitopes. The appropriate region in B-cell epitopes was
chosen for cloning. The presence of recombinant protein was detected with immunological methods. Subsequently, BALB/C mice
were immunized with the recombinant protein and alpha toxin, and the antibodies produced were evaluated by dot-blot and ELISA
tests. After cloning the highly antigenic region (1799–1966 amino acid residues), the results of immunological tests showed that the
recombinant protein reacts with antitoxin antibodies. Antirecombinant protein has a higher affinity to the alpha toxin than antialpha
toxin. Thus, the carboxyl terminal of the protein (1799–1966 amino acid residues) in B-cell epitopes could be a proper candidate for a
peptide vaccine against alpha toxin.
Key words: Alpha toxin, Clostridium novyi, antigenic regions, conformational epitope, homology modeling

1. Introduction
Clostridium novyi causes gangrene in humans and animals.
Among the various toxins produced by this pathogen
(Hatheway, 1990), alpha toxin has a molecular weight of
approximately 200–250 kDa and enzymatic activity on
Rho receptors in mammalian cells, which cause vascular
permeability and cell rounding in culture (Bette et al.,
1991). Homology studies have shown that alpha toxin
belongs to the large clostridial cytotoxin family (Hofmann
et al., 1995). This family comprises glycosyltransferase
by modifying small GTP-binding proteins, such as Rho
and Ras, which inhibit signal pathways, thereby causing
cytoskeletal disintegration (Oksche et al., 1992), which in
turn causes cell death. Alpha toxin has a tripartite structure
in which the enzymatic activity is related to a 551-amino
acid on the N-terminal, known as the catalytic domain
(Busch et al., 2000). The C-terminal of the toxin is the
receptor-binding domain, and the hydrophobic domain in
the central region is required for the translocation of the
toxin into cytosol (von Eichel-Streiber et al., 1996).
Vaccination is an effective means for the control of
this disease. Whole-cell and toxoid vaccines are available,
yet they have drawbacks such as incomplete inactivation
and possible side effects. The use of recombinant DNA
technology could result in antigens with high purity and
* Correspondence: najafi99@yahoo.com

safety (Fox and Klass, 1989). Protective antibodies against
this recombinant antigen could react to the whole antigen
and effective vaccines, producing the need to identify
B-cell epitopes (Atassi et al., 2012). Therefore, epitope
prediction is useful for the production of subunit and
synthetic peptide vaccines and antibodies or antisera for
competition assays.
Identification of B-cell epitope locations has been
carried out with both experimental and computational
methods. In some experimental approaches, overlapping
peptide was synthesized and bound to the antibody against
the whole antigen (Atassi et al., 2011). Experimental
techniques are time-consuming and expensive;
furthermore, in the case of large proteins, it is laborious to
carry out epitope mapping. Therefore, several prediction
tools have been developed for identifying appropriate parts
of protein as epitopes (Irving et al., 2001). This prediction
is based on using computational methods and resources
to extract immunological information and is known as
immunoinformatics (Tomar and De, 2014).
In this study, we designed a strategy to produce highly
antigenic regions based on immunoinformatics methods
in the recognized epitopic region, according to continuous,
discontinuous, and T-cell epitopes. Production of
antibodies was elicited by the immunization of mice
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with the recombinant protein. The ELISA test was used
to evaluate the cross-reaction of antirecombinant protein
with native toxin.
2. Materials and methods
2.1. Protein sequence analysis
The nucleotide sequence of the alpha toxin of
Clostridium novyi was retrieved from the NCBI database
(gi|728537|emb|Z48636.1|). The protein sequence and
reading frame of alpha toxin were then predicted with
ExPASy and CLC Main Workbench 6, and a translation
frame was identified.
2.2. Prediction of protein secondary structure
The secondary structure (α-helix and β-sheet) of alpha
toxin was predicted with CLC Main Workbench 6, after
which the protein sequence was divided into 13 fragments
(regions) with overlaps in order to aim for antigenicity
and cloning in the future. Each fragment was designed to
retain beta sheet and alpha helix structures.
2.3. B-cell and T-cell epitope identification
The IEDB and Bcepred servers were utilized to predict
linear B cell epitopes. MHC class II epitopes were analyzed
with the IEDB server.
Antigenic sites were determined by using the IEDB
server and the Kolaskar and Tongaonkar antigenicity
method. This program uses experimental antigenic
determinant data and the physicochemical properties
of amino acid residues (Kolaskar and Tongaonkar,
1990). The Bcepred server was used to predict the linear
B-cell epitope based on physicochemical properties
(hydrophilicity, flexibility/mobility, accessibility, polarity,
exposed surface, and turns) (Saha and Raghava, 2004).
The IEDB server predicts MHC class II epitopes by using
a consensus approach that combines NN-align, SMMalign, and combinatorial library methods (Wang et al.,
2008). Since BALB/C mice were subjected to experimental
analysis, an H2-IAd allele with more frequency in BALB/C
was selected for the analysis (Ru, 2012).
2.4. Homology modeling and quality evaluation
Homology modeling of the alpha toxin was carried out
with I-TASSER. This server generates 3D models based on
multiple threading alignments. In I-TASSER, the C-score
was used to determine the accuracy of the models, after
which the model with the highest C-score was used for
further analysis (Roy et al., 2010). Since the I-TASSER
server only accepts sequences with <1500 residues, a
region between 687 and 2178 amino acids was used for
prediction (1500 residues). Swiss-Pdb Viewer 4.10 was
used for energy-minimizing the best model (http://www.
expasy.org/spdbv/) and, subsequently, Ramachandran plot
analysis was carried out with RAMEPAGE (Lovell et al.,
2003).
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2.5. Identification of conformational epitope
The Discotope 2.0 server was used for identifying
discontinuous epitopes by using a 3D structure. The
predicted epitope is based on surface accessibility and the
epitope propensity amino acid score (Kringelum et al.,
2012). Epitopes in each fragment (region) were analyzed,
and the fragment with the highest antigenicity was selected.
2.6. Analyzing the primary structure, restriction enzyme
sites, and primer design
An antigenic region, selected on the basis of
immunoinformatic studies, was chosen for cloning and
recombinant protein production. To characterize and
purify the recombinant protein, analysis of the primary
structure of the fragment with the Bioinformatics Server
was helpful. ProtParam is a tool that computes the physical
and chemical parameters of protein such as molecular
weight, theoretical pI, and amino acid composition
(http://web.expasy.org/protparam/) (Gasteiger et al.,
2005). NEBcutter 2.0 was used for the identification of
restriction enzyme sites in the fragment (http://nc2.neb.
com/NEBcutter2/). The primer sequence position was
selected and designed with PrimerPremier 5: forward 5’AAT GGA GAG CTT CAT TAC AAA AAT, reverse 5’TTC TTC CCA ATT TCC ATT TAT ATT.
2.7. DNA extraction and PCR amplification of the
antigenic fragment
C. novyi was obtained from the Razi Vaccine and Serum
Research Institute, Mashhad, Iran. Clostridium novyi was
grown in 1 L of medium, based on the medium described
by Guan et al. (2011). Genomic DNA of Clostridium
novyi was extracted with the phenol-chloroform method
(Cheng and Jiang, 2006). PCR was carried out using Taq
DNA polymerase. An antigenic fragment was amplified
separately in a 40-µL volume. The annealing temperature
for the antigenic fragment was 56 °C, and 30 cycles were
repeated. All PCR steps had a duration of 40 s, except for
an additional extension time of 10 min at 72 °C. Antigenic
fragment (570 bp) amplicons were obtained and purified
from the agarose gel (Sambrook et al., 2001).
2.8. Molecular cloning and sequencing of the antigenic
fragment
The purified fragments were ligated in TA cloning vector
pTZ57R/T. After transforming in DH5α E. coli, the
desired plasmid construction was confirmed by PCR and
extracted by the alkaline method (Sambrook et al., 2001).
The recombinant plasmids and the pET-21a(+) vector
were digested by SalI-EcoRI enzymes. The fragments
were inserted into the pET-21a(+) vector and transformed
into E.coli BL21 Codon plus. The positive clones were
selected by blue-white screening (containing 100 µg
mL–1 ampicillin, 40 µg mL–1 X-gal, and 40 µg mL–1 IPTG)
and PCR testing and were sequenced for verification by
Macrogen Company (Seoul, Korea).
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2.9. Recombinant protein expression
The positive clone construct pET21a-ATF12 was cultured
in LB broth containing 100 µg mL–1 ampicillin and
was incubated at 37 °C and 200 rpm. After 16 h, it was
transferred to LB medium (1 L) containing ampicillin and
was incubated at 37 °C and 200 rpm. At an optical density
of around 0.5 at 600 nm absorption, the culture was
induced by adding 1 mM IPTG and this was continued for
the next 4 h.
2.10. Cell lysate and partial purification of recombinant
protein
The cells were harvested by centrifugation at 5000 rpm for
15 min. Cell lysis was performed according to the method
of Sarma et al. (2000). Cell lysate was precipitated by 40%
ammonium sulfate and partially purified by gel filtration
(G50 Sephadex) chromatography. The recombinant
protein activity was checked by ELISA and precipitated by
40% ammonium sulfate for further use in experiments.
2.11. Sandwich ELISA for determination of the
recombinant protein
ELISA testing was used to evaluate the amount of
recombinant protein. A polyvinyl chloride 96-well
plate (SPL strips immunoplates) was coated with 100
µL of 1 µg/mL antialpha toxin solution (antialpha toxin
was prepared in the Razi Vaccine and Serum Research
Institute, developed in rabbit). The assay was performed as
described by McGregor et al. (1994).
2.12. SDS-PAGE and western blotting
SDS-PAGE were performed according to Laemmli
(1970). The recombinant protein cell lysate and purified
recombinant protein were separated on 12.5% SDS-PAGE
gel. Silver staining of the gel was used to detect protein.
Gel was blotted onto a nitrocellulose membrane and
nonspecific binding was blocked with PBS (1.5%) for 1
h at 37 °C. The membrane was incubated with anti-His
Tag HRP-conjugated antibody (1/2000) for 1 h at 37 °C.
The membrane was washed three times in PBS-T (0.05%
Tween-20) and three times in PBS, and then DAB substrate
was used for detection.

2.13. Immunization
Three BALB/C mouse groups were separately immunized
against 200 µg of recombinant protein, whole alpha toxin
(formaldehyde-inactivated), and PBS as negative control.
Chitosan was used as an adjuvant (de Paz et al., 2011). Each
group consisted of 3 mice that were injected weekly for 3
weeks. Bleeding of mice was carried out 7 days after the
last injection. The sera were separated by centrifugation,
and each group was mixed and stored at –20 °C until
further analysis.
2.14. Characterization of mouse antibodies by crosscheck
A dot-blot test was prepared on nitrocellulose membrane
to detect anti-pNTF12 in mouse serum. This test was
performed according to Towbin and Gordon (1984).
BL21 lysate and PBS were used as negative controls in the
test, and the membrane was purchased from Amersham
Company (Little Chalfont, UK). Cross-reactions between
the antirecombinant protein, antialpha toxin, and anti-PBS
(all were diluted to 1:100) and 1 µg/mL solutions of native
alpha toxin and the recombinant protein were carried out
by ELISA test. This test was performed to measure serum
responses to recombinant protein and native antigen.
3. Results
The secondary structure prediction of the alpha toxin
with CLC Main Workbench 6 showed that the C-terminal
region of the protein has more β-sheet structures than the
N-terminal. As shown in Figure 1, the protein sequence
was divided into 13 fragments (NTF1–NTF13) with
overlapping sequences.
The second part of the protein showed higher
antigenicity than the first. The outcome of the two servers
(IEDB and Bcepred) showed that fragments in the middle
(NTF7, NTF8, NTF11, NTF12, and NTF13) and the
C-terminal of the toxin were found to be antigenic in
linear B-cell epitopes.
The IEDB outcome of T-cell epitopes revealed
those residues in 3–17 (ITREQLMKIASIPLK),

Figure 1. Putative domain organization of alpha toxin (Busch et al., 2000; Nagahama et al., 2012).
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965–979 (LNSAMLMQLLIDYKP), and 983–997
(ILTNMNTSLKVQAYA), which are in NTF1 and NTF7,
respectively. These fragments have high potential for
binding to MHCII.
The overall analyses of the secondary structure,
antigenicity plot of the B-cell epitope, and T-cell epitope
results showed that the C-terminal region of the protein
(+1000 aa) is more antigenic because the beta-sheet strand
is more antigenic (Ingale, 2010).
The 3D structure of the whole alpha toxin protein is
not available in PDB; therefore, the I-TASSER server
was used for prediction. The I-TASSER input sequence
has restrictions (<1500) and, according to the results of
the linear B-cell and T-cell epitopes analysis that showed
the N-terminal of alpha toxin (687 residues in the
beginning), it is less epitopic than the C-terminal of the
toxin. Therefore, the N-terminal was omitted in further
analysis. Residues between 687 and 2178 were selected
for homology modeling. The model with the highest
C-score was subjected to energy-minimizing with SwissPdb Viewer and Ramachandran plot analysis in order to
validate the geometrical structure as a native-like protein.
As shown in Figure 2, the alpha toxin model has 90.8% of
amino acid residues in favored regions, 6.6% in allowed
regions, and 2.6% in outlier regions. Therefore, the 3D
structure of alpha toxin was confirmed and visualized with
PyMOL (Figure 3).
The conformational epitope was predicted with
Discotope 2.0 (Figure 4). Results from Discotope identified
126 residues as epitopes of 1500 total residues with 62

epitopes located in NTF12 (Table). Thus, NTF12 showed
high antigenicity with the B-cell epitope prediction tools
(continuous and discontinuous). Consequently, this
region was chosen for further experimental evaluation
using different proteomic techniques.
The primer sequences were designed for the
amplification of NTF12. The primary structure shows
that pNTF12 (the recombinant protein of NTF12) has a
molecular weight of 22.5 kDa. A bioinformatics analysis
of restriction enzyme sites shows the absence of SalI and
EcoRI restriction sites in the fragment. Therefore, these
restriction enzymes could be used to transform the NTF12
fragment from the pTZ vector and for subcloning into the
pET-21a(+) expression vector.
PCR amplification of NTF12 resulted in a PCR product
of 570 bp. The pET21a-NTF12 constructs were verified by
PCR test and confirmed by DNA sequencing (data not
shown).
Expression and antigenicity of pNTF12 were evaluated
by ELISA testing (data not shown). It was observed that
the antialpha toxin reacted with pNTF12, and it is hence
suggested that the NTF12 region, as immunoinformatic
analyses have shown, is an immunodominant region
that reacts with antialpha toxin. After gel filtration
chromatography, the partially purified pNTF12 was
used for further analysis. The presence and purification
of pNTF12 was also detected on polyacrylamide gel and
western blotting analysis (Figure 5). Dot-blotting results
indicated that anti-pNTF12 could react to both pNTF12
and native alpha toxin (Figure 6). With immunological

Figure 2. The Ramachandran plot for alpha toxin (region 684–2178) by RAMPAGE
server.
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Figure 3. The 3D structure of the alpha toxin (687–2178 residues)
model visualized by PyMOL.

Figure 4. Discontinuous epitope predictions by Discotope
2.0 server; the structure was colored blue to red based on its
Discotope 2.0 score. Blue indicates low epitope possibility and
red indicates high possibility to be an epitope residue.

Table. Predicted conformational B-cell epitopes by Discotope 2.0 server.
Fragment

Region
(amino acids)

Epitopic region

Number of
epitopic region

NTF5

593–806

691–692, 705–706, 708, 710

6

NTF6

782–944

856–857, 861–862, 864–866, 890, 892, 907, 943

11

NTF7

923–1125

994

NTF8

1097–1299

1151, 1223, 1224, 1227

1
4

NTF9

1264–1490

1377–1379, 1401

NTF10

1447–1648

1581, 1612, 1614

3

NTF11

1615–1822

1697–1699, 1701–1709, 1711–1712

14

NTF11 & 12 (overlap region)

1784–1822

1800–1804, 1808

5

NTF12

1784–1974

1832, 1834–1837, 1839–1841, 1843–1844, 1869, 1871,
1875, 1881–1885, 1887-1891, 1901–1911, 1924–1930

42

NTF12 & 13 (overlap region)

1952–1974

1943–1956,1958

15

NTF13

1952–2178

1975–1977, 1979, 1981, 2039, 2047, 2061–2071, 2101,
2102, 2130

21

Total epitopes

cross-reactivity, it was revealed that anti-pNTF12 could
react to alpha toxin, which is 2.35-fold more reactive
to alpha toxin than native antialpha toxin (Figure 7).
According to the experimental analysis, NTF12 predicted
by immunoinformatics methods has immunodominant
epitopes and therefore shows high antigenicity.

4

126

4. Discussion
Clostridium novyi is a spore-forming bacterium with a
lethal toxin called alpha toxin, which causes gas gangrene
in humans and animals. Alpha toxin causes edema that
could lead to necrotic infections (Busch et al., 2000;
McGuigan et al., 2002).
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Figure 5. Analysis of expressed and purified recombinant protein: A) SDS-PAGE gel
(12.5%) and B) western blotting by using anti-His Tag HRP-conjugated antibody against
pNTF12. M: Prestained protein molecular weight marker, #26612.
BL21 lysate was used as a negative control.

Figure 6. Dot-blot test using anti-pNTF12 against pNTF12 and native alpha toxin. BL21 lysate
and PBS were used as negative controls.

In our study, the second section of alpha toxin (residues
>1000) has more antigenicity due to the beta sheet and coil
structures. A B-linear antigenicity report shows that NTF7,
NTF8, NTF11, NTF12, and NTF13 contain more antigenic
determinants. NTF12 (1800–1958 amino acid residues)
in conformational epitope analysis was introduced as
a highly antigenic fragment. It was shown that >90% of
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B-cell epitopes are discontinuous (Barlow et al., 1986).
NTF1 and NTF7 in the amino terminal and central
sections of the toxin were shown to be suitable binders
to MHCII. It is suggested that the highest antigenicity of
the terminal segment of the toxin is in its receptor binding
activity, which is located on the protein surface and has
high mobility.

GORD-NOSHAHRI et al. / Turk J Biol

Relative reaction

3

Comparision of anti -NTF12 and antialpha toxin
against native alpha toxin

2
1

2.35
1

0

Anti-NTF12

Antialpha toxin

Figure 7. Cross-reaction of anti-NTF12 against native alpha
toxin and compared with an antialpha toxin.

An analysis of the secondary structure of the protein
showed that antigenic determinants are often found in
loop-like structures on the surface of a molecule (Modrow
et al., 1987). Other studies showed that beta sheet regions
have a higher immunity response compared to the helical
regions (Ingale, 2010).
An overall immunoinformatic analysis revealed that
NTF12 is common in linear and conformational epitope
analysis, making it a suitable candidate for inducing
immunity. An advantage of NTF12 is that it is nontoxic
due to the absence of a catalytic domain (N-terminal).
Based on our immunoinformatics analyses, NTF12
was chosen for production in E. coli cells, since it showed
immunogenic potential. Immunological tests showed
that pNTF12 was strongly recognized by antialpha toxin
antibodies; therefore, it is suggested that this region
has high antigenicity. Anti-NTF12 produced in mice
recognized the alpha toxin and also had significantly
higher reactivity to the native toxin than antialpha toxin.
Thus, it seems that the NTF12 region could be used as
an appropriate immunogen. We propose that the 3D

structure and epitopes of the pNTF12 of alpha toxin
is retained, preserving its native form. This is similar to
the findings reported by Atassi et al. (2012), who showed
that an antibody prepared by immunization with surfacestimulation peptide had a high level of cross-reaction with
native protein.
The production of traditional clostridial vaccines is
an expensive, laborious, and hazardous process, because
of necessary toxin inactivation and purification stages
(Haesebrouck et al., 2004; Nijland et al., 2007). Alpha toxin
is a large protein with 2178 amino acids. Since a small
fragment of an antigen can induce an immune response
against the whole antigen, cloning and production of the
regions with high antigenicity has opened new possibilities
for immunity against lethal toxins. This study indicates
various bioinformatics tools to determine potential
antigenic regions (B-cell and T-cell epitopes) in alpha
toxin, with the aim of producing this region in heterologous
systems and immunization. Overall, our bioinformatics
analysis has shown that the carboxyl terminal of the toxin
as a highly antigenic region has a high probability for
humoral immune response (B-cell epitope). In addition,
for vaccine development, NTF1 or NTF7 could be used as
a T-cell epitope. pNTF12 retains proper folding, which is
essential for conformational epitopes due to the antibodies
generated after mouse immunization with recombinant
protein that is able to recognize the native alpha toxin.
Furthermore, pNTF12 displays no toxicity after the
immunization of mice. This evidence indicates that in
silico analysis of antigenic regions, followed by in vitro
and in vivo experiments, could be an effective strategy for
considering a proper candidate for vaccine development.
This strategy can be used for designing peptide vaccines
and diagnostic tests.
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